Journal of Experimental Medicine, Vol 174, 837-845, Copyright © 1991 by Rockefeller University Press

ARTICLES

Leukemia inhibitory factor improves survival of retroviral vector- infected hematopoietic stem cells in vitro, allowing efficient long- term expression of vector-encoded human adenosine deaminase in vivo

FA Fletcher, KA Moore, M Ashkenazi, P De Vries, PA Overbeek, DE Williams and JW Belmont
Institute for Molecular Genetics, Baylor College of Medicine, Houston, Texas 77030.

Low recovery and poor retroviral vector infection efficiency of hematopoietic stem cells has hindered application of gene therapy for disease affecting blood-forming tissues. Developmental restriction (or death) of stem cells during ex vivo infection has contributed to these difficulties. In these studies we report that the cytokine leukemia inhibitory factor (LIF) directly or indirectly supported the survival of hematopoietic stem cells during culture of bone marrow with vector- producing fibroblasts, resulting in efficient recovery of stem cells able to compete for engraftment in irradiated recipient animals. The infection efficiency of hematopoietic stem cells recovered from these cultures was approximately 80%; and all recipients (20/20) of the LIF- treated marrow were stably engrafted with the progeny of provirus- bearing stem cells. Expression of vector-encoded human adenosine deaminase (hADA) was detected in all recipients at levels averaging 15- 50% of endogenous murine ADA in all their hematolymphoid tissues. Survival of stem cells in untreated cultures was approximately 10% of that observed from LIF-treated cultures, resulting in poor engraftment of recipient animals with transplanted cells. The infection efficiency of the few stem cells recovered from untreated cultures, however, was high (approximately 80%), suggesting that LIF did not have an effect on infection efficiency per se, but acted at the level of stem cell survival. Consistent with the poor engraftment observed in the control animals, expression of vector-encoded ADA was only approximately 4-20% of the endogenous levels. These results support the postulated role of LIF as a regulator of hematopoiesis and suggest that cytokine stimulation can positively affect inefficient retroviral vector transduction in hematopoietic stem cells.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• McPherson, S. W., Roberts, J. P., Gregerson, D. S. (1999). Systemic Expression of Rat Soluble Retinal Antigen Induces Resistance to Experimental Autoimmune Uveoretinitis. J. Immunol. 163: 4269-4276 [Abstract] [Full Text]  
• Dao, M. A., Hannum, C. H., Kohn, D. B., Nolta, J. A. (1997). FLT3 Ligand Preserves the Ability of Human CD34+ Progenitors to Sustain Long-Term Hematopoiesis in Immune-Deficient Mice After Ex Vivo Retroviral-Mediated Transduction. Blood 89: 446-456 [Abstract] [Full Text]  
• Ware, C., Horowitz, M., Renshaw, B., Hunt, J., Liggitt, D, Koblar, S., Gliniak, B., McKenna, H., Papayannopoulou, T, Thoma, B, et, al. (1995). Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121: 1283-1299 [Abstract]  
• Sorrentino, B., Brandt, S., Bodine, D, Gottesman, M, Pastan, I, Cline, A, Nienhuis, A. (1992). Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257: 99-103 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS